WAYNE, Pa.--(BUSINESS WIRE)--Jan. 22, 2016--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care, urology and surgery, will showcase its Arrow®
GPSCath® Interventional Product Platform at the Leipzig Interventional
Course (LINC) to be held in Leipzig, Germany on January 26 - 29, 2016.
During the event, Teleflex will highlight the Arrow® GPSCath® Balloon
Dilatation Catheter, which features VisioValve™ Technology. The GPSCath®
Catheter is a specialty two-in-one device that is indicated for
percutaneous transluminal angioplasty (PTA) in the peripheral
vasculature, including the iliac, femoral, popliteal, infrapopliteal and
renal arteries.
Teleflex is pleased to present its Arrow® GPSCath® Catheter at three
Satellite Symposiums during the event. The first presentation will be
given by Dr. Marco Manzi from Policlinico Abano Terme, Italy and is
entitled “Use of the Arrow® GPSCath® Catheter in a diabetic patient
population with impaired renal function.” This presentation will be held
at the Global Expert Exchange, Room 5, on Tuesday, January 26 at 15:24h.
The second presentation will be given by Prof. Marc Sapoval from Hôpital
Européen Georges Pompidou, Paris, France and is entitled “Strategies in
challenging BTK procedures: Arrow® GPSCath® Catheters with VisioValve™
Technology to protect wire placement, reduce fluoroscopy-time and
minimize contrast media.” This presentation will be held on Thursday,
January 28, at 11:00h, at Technical Forum, Room 3.
The third presentation is entitled “Contrast saving strategies for BTK
recanalization with the Arrow® GPSCath® Catheter,” and will be given by
Dr. Costantino Del Giudice from Hôpital Européen Georges Pompidou,
Paris, France on Thursday, January 28, at 16:23h, at Main Arena 1, Room
1.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rüsch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, GPSCath, Hudson RCI,
LMA, Pilling, Rusch, VisioValve and Weck are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates, in the U.S.
and/or other countries. © 2016 Teleflex Incorporated. All rights
reserved.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160122005060/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com